-+ 0.00%
-+ 0.00%
-+ 0.00%

ARMATA PHARMACEUTICALS, - TO INITIATE PHASE 3 SUPERIORITY STUDY OF AP-SA02 IN H2 2026

Reuters·09/14/2026 11:00:02

Please log in to view news